Cathepsin K (BSB-172), MMab

Description

Cathepsin K is a cysteine protease, which may be secreted as a pro-enzyme and is activated in a low-pH environment such as lysosomes. Cathepsin K accepts Arg and Lys residues at the P1 active site, acting on Proteolytically Activated Receptors (PARs) in extracellular matrix. Cathepsin K also cleaves collagen and degrades bone matrix, and is involved in the mTOR signaling pathway of cellular autophagy and apoptosis. Cathepsin K has also been shown to play a role in MHC II antigen presentation, keratinocyte differentiation, platelet aggregation, and in the Hedgehog signaling pathway. As a protease active in the extracellular matrix and lysosomes, Cathepsin K has been implicated in cancer progression and invasiveness. Cathepsin K has been shown to have specific proteolytic activity on PAR-3 and PAR-4, which are expressed in the EMC of epithelial-mesenchymal cells in breast cancer. Proteolytic cleavage of PARs stimulates platelet aggregation and p38 phosphorylation in the MAPK pathway. Cathepsin K-induced proteolytic cleavage induces upregulation of proteins related to metastasis in bone and prostate cancer, and epithelial-mesenchymal-like cells in breast cancer.

Caractéristiques

Type

Mouse Monoclonal

Clone

BSB-172

Isotype

IgG1, Kappa

Réactivité

Paraffin, Frozen

Localisation

Cytoplasmic

Contrôle

Breast, Liver

Usage prévu

For In Vitro Diagnostic Use